ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia
A study led by The University of Texas MD Anderson Cancer Center, USA, showed that…
Browsing: ASH 2020
ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers
Knocking out a protein known to stifle T cell activation on CAR T cells using…
ASH 2020: Early phase studies show promise in acute myeloid leukaemia
Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive…
ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels…